METHOD early treatment of hemorrhagic shock

摘要

method of early therapy of hemorrhagic shock, including the introduction of u043au0440u0438u0441u0442u0430u043bu043bu043eu0438u0434u043eu0432 and u043au043eu043bu043bu043eu0438u0434u043eu0432, 5% dextrose and insulin, u043au0430u043bu0438u00a0 chloride, chloride u043au0430u043bu044cu0446u0438u00a0, sul u044cu0444u0430u0442u043eu043c u043cu0430u0433u043du0438u00a0, plasma, packed red blood u043eu0434u043du043eu0433u0440u0443u043fu043du043eu0439 mass, 20% solution of glucose with insulin, u043fu0440u043eu0432u0435u0434u0435u043du0438u00a0 u0438u043du043eu0442u0440u043eu043fu043du043eu0439 u0441u0442u0438u043cu0443u043bu00a0u0446u0438u0438, u043eu0442u043bu0438u0447u0430u044eu0449u0438u0439u0441u00a0 what sick d. u043eu043fu043eu043bu043du0438u0442u0435u043bu044cu043du043e u0432u0432u043eu0434u00a0u0442 7.5% saline u043du0430u0442u0440u0438u00a0 chloride, u0434u0430u043bu0430u0440u0433u0438u043d or u043cu0438u043bu0434u0440u043eu043du0430u0442,u043au043eu043du0442u0440u0438u043au0430u043b, heparin, u0430u0441u043au043eu0440u0431u0438u043du043eu0432u0443u044e acid, vitamin b6, u0440u0438u0431u043eu043au0441u0438u043d, u043fu0435u043du0442u0430u043cu0438u043d and infusion therapy u043fu0440u043eu0432u043eu0434u00a0u0442 mainly u043au0440u0438u0441u0442u0430u043bu043bu043eu0438u0434u043du044bu043cu0438 solutions, with u0432u043du0430u0447 but in the central vein u0432u0432u043eu0434u00a0u0442 7.5% saline u043du0430u0442u0440u0438u00a0 chloride 200-300 ml, u0434u0430u043bu0430u0440u0433u0438u043d 0.001 - 0.003 g or in u0441u0438u0441u0442u043eu043bu0438u0447u0435u0441u043au043eu043c arterial pressure below 90 mm,. art.- u043cu0438u043bu0434u0440u043eu043du0430u0442 10% - 5 - 6 ml, then under the control of the central venous u0434u0430u0432u043bu0435u043du0438u00a0 u0432u0432u043eu0434u00a0u0442 0.9% saline u043du0430u0442u0440u0438u00a0 chloride 400 - 800 ml of 5% glucose solution, 400 - 800 ml with insulin 6 - 12 units and chlorine u0438u0434u043eu043c u043au0430u043bu0438u00a0 4% solution of 20 to 30 ml, chloride u043au0430u043bu044cu0446u0438u00a0 10% solution - 8 - 10 ml 25% u043cu0430u0433u043du0438u00a0 sulphate solution 4 - 6 ml 0.9% saline u043du0430u0442u0440u0438u00a0 chloride 400 - 800 ml with u043au043eu043du0442u0440u0438u043au0430u043bu043eu043c 20 - 40 u0442u044bu0441u00a0u0447 ed, fpi a 500 - 800 mlu043eu0434u043du043eu0433u0440u0443u043fu043du0443u044e plasma 600 - 800 ml heparin 3000 - 4000 iu, iv '0.9% solution u043du0430u0442u0440u0438u00a0 chloride 20 ml, then in u043fu0435u0440u0438u0444u0435u0440u0438u0447u0435u0441u043au0443u044e vein u0432u0432u043eu0434u00a0u0442 u0430u0441u043au043eu0440u0431u0438u043du043eu0432u0443u044e acid 5% - 4 - 6 ml users' 40% glucose solution 15 ml, u0440u0438u0431u043eu043au0441u0438u043d 8 - 10 ml intravenous 0.9% solution 'u043du0430u0442u0440u0438u00a0 chloride 10 ml vitamin b6 (1 - 2 ml intravenous' 20 ml 0.9% solution u043du0430u0442u0440u0438u00a0 chloride.in the central vein, continue to the introduction of 20% dextrose 300 - 400 ml with insulin 20 - 26 units of packed red cells, u043fu0440u043eu0432u043eu0434u00a0u0442 u0433u0435u043cu043eu0442u0440u0430u043du0441u0444u0443u0437u0438u044e u043eu0434u043du043eu0433u0440u0443u043fu043du043eu0439 mass of 400 - 600 ml, with u043du0435u0441u0442u0430u0431 u0438u043bu044cu043du043eu0439 u0433u0435u043cu043eu0434u0438u043du0430u043cu0438u043au0435 continued injection 0.9% saline u043du0430u0442u0440u0438u00a0 chloride with u0438u043du0444u0443u0437u0438u0435u0439 dopamine 5 - 10 mg / kg / min, and after stabilization u0433u0435u043cu043eu0434u0438u043du0430u043cu0438u0447u0435u0441u043au0438u0445 pok u0430u0437u0430u0442u0435u043bu0435u0439 correction volume of circulating bloodu0434u0430u043bu0430u0440u0433u0438u043d set to 0.001 - 0.003 intramuscular 2 times a day, or a set u043cu0438u043bu0434u0440u043eu043du0430u0442 on 5 to 6 ml of 10% saline intravenously in 15 ml of 0.9% saline u043du0430u0442u0440u0438u00a0 chloride 1 time a day for 10 to 14 days and u043fu0435u043du0442u0430u043cu0438u043d 5% solution of 0.3 - 0.5 ml intramuscular 3 times a day, for 3 to 5 days.